<?xml version='1.0' encoding='utf-8'?>
<document id="32150479"><sentence text="Effects of multidose simvastatin co-administration on pharmacokinetic profile of apatinib in rats by UPLC-MS/MS."><entity charOffset="21-32" id="DDI-PubMed.32150479.s1.e0" text="simvastatin" /><entity charOffset="81-89" id="DDI-PubMed.32150479.s1.e1" text="apatinib" /><pair ddi="false" e1="DDI-PubMed.32150479.s1.e0" e2="DDI-PubMed.32150479.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32150479.s1.e0" e2="DDI-PubMed.32150479.s1.e1" /></sentence><sentence text="Apatinib, a small molecule anti-angiogenic tyrosine kinase inhibitor is used extensively to treat advanced gastric cancer and simvastatin (SV) is often co-prescribed to treat cardiovascular disease in cancer patients"><entity charOffset="0-8" id="DDI-PubMed.32150479.s2.e0" text="Apatinib" /><entity charOffset="43-51" id="DDI-PubMed.32150479.s2.e1" text="tyrosine" /><entity charOffset="126-137" id="DDI-PubMed.32150479.s2.e2" text="simvastatin" /><entity charOffset="139-141" id="DDI-PubMed.32150479.s2.e3" text="SV" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e0" e2="DDI-PubMed.32150479.s2.e0" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e0" e2="DDI-PubMed.32150479.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e0" e2="DDI-PubMed.32150479.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e0" e2="DDI-PubMed.32150479.s2.e3" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e1" e2="DDI-PubMed.32150479.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e1" e2="DDI-PubMed.32150479.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e1" e2="DDI-PubMed.32150479.s2.e3" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e2" e2="DDI-PubMed.32150479.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32150479.s2.e2" e2="DDI-PubMed.32150479.s2.e3" /></sentence><sentence text=" As both apatinib and SV are metabolized primarily by cytochrome P450 variant CYP3A4, they are likely to interact"><entity charOffset="9-17" id="DDI-PubMed.32150479.s3.e0" text="apatinib" /><entity charOffset="22-24" id="DDI-PubMed.32150479.s3.e1" text="SV" /><pair ddi="false" e1="DDI-PubMed.32150479.s3.e0" e2="DDI-PubMed.32150479.s3.e0" /><pair ddi="false" e1="DDI-PubMed.32150479.s3.e0" e2="DDI-PubMed.32150479.s3.e1" /></sentence><sentence text=" Therefore, the potential effect of SV co-administration on pharmacokinetics of apatinib in Sprague-Dawley male rats is demonstrated for the first time"><entity charOffset="36-38" id="DDI-PubMed.32150479.s4.e0" text="SV" /><entity charOffset="80-88" id="DDI-PubMed.32150479.s4.e1" text="apatinib" /><pair ddi="false" e1="DDI-PubMed.32150479.s4.e0" e2="DDI-PubMed.32150479.s4.e0" /><pair ddi="false" e1="DDI-PubMed.32150479.s4.e0" e2="DDI-PubMed.32150479.s4.e1" /></sentence><sentence text="Sixteen rats were randomly divided into two groups (n = 8), 2 mg/kg SV orally co-administrated for seven days (group B) and the corresponding control group (group A)"><entity charOffset="68-75" id="DDI-PubMed.32150479.s5.e0" text="SV" /></sentence><sentence text=" Apatinib concentrations of rat plasma samples were detected by ultra-performance liquid chromatography tandem mass spectrometry" /><sentence text=" Pharmacokinetic parameters were calculated using non compartmental methods" /><sentence text="Co-administration of SV for seven days significantly increased area under curve (AUC(0-t)), AUC(0-∞) and maximum plasma concentration of apatinib by 2"><entity charOffset="21-23" id="DDI-PubMed.32150479.s8.e0" text="SV" /><entity charOffset="137-145" id="DDI-PubMed.32150479.s8.e1" text="apatinib" /><pair ddi="false" e1="DDI-PubMed.32150479.s8.e0" e2="DDI-PubMed.32150479.s8.e0" /><pair ddi="false" e1="DDI-PubMed.32150479.s8.e0" e2="DDI-PubMed.32150479.s8.e1" /></sentence><sentence text="4-, 2" /><sentence text="4-, and 2" /><sentence text="7-fold, respectively while decreasing apparent volume of distribution and clearance by 81" /><sentence text="7 and 73" /><sentence text="9%, respectively" /><sentence text="These findings suggest that concomitant administration of SV with 7 days may have inhibited the metabolism of apatinib in rats"><entity charOffset="58-60" id="DDI-PubMed.32150479.s14.e0" text="SV" /><entity charOffset="110-118" id="DDI-PubMed.32150479.s14.e1" text="apatinib" /><pair ddi="false" e1="DDI-PubMed.32150479.s14.e0" e2="DDI-PubMed.32150479.s14.e0" /><pair ddi="false" e1="DDI-PubMed.32150479.s14.e0" e2="DDI-PubMed.32150479.s14.e1" /></sentence><sentence text="" /></document>